181 related articles for article (PubMed ID: 27616706)
1. Adjunctive Corticosteroids for Pneumocystis jirovecii Pneumonia in Non-HIV-infected Patients: A Systematic Review and Meta-analysis of Observational Studies.
Fujikura Y; Manabe T; Kawana A; Kohno S
Arch Bronconeumol; 2017 Feb; 53(2):55-61. PubMed ID: 27616706
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.
Briel M; Bucher HC; Boscacci R; Furrer H
Cochrane Database Syst Rev; 2006 Jul; (3):CD006150. PubMed ID: 16856118
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection.
Ewald H; Raatz H; Boscacci R; Furrer H; Bucher HC; Briel M
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD006150. PubMed ID: 25835432
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials.
Briel M; Boscacci R; Furrer H; Bucher HC
BMC Infect Dis; 2005 Nov; 5():101. PubMed ID: 16271157
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia.
Inoue N; Fushimi K
Int J Infect Dis; 2019 Feb; 79():109-115. PubMed ID: 30529109
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
Green H; Paul M; Vidal L; Leibovici L
Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS; Lu JJ; Perng CL; Chang FY
J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
Yu Q; Jia P; Su L; Zhao H; Que C
BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Bozzette SA; Sattler FR; Chiu J; Wu AW; Gluckstein D; Kemper C; Bartok A; Niosi J; Abramson I; Coffman J
N Engl J Med; 1990 Nov; 323(21):1451-7. PubMed ID: 2233917
[TBL] [Abstract][Full Text] [Related]
11. [Pneumocystis Pneumonia in 107 HIV Infected Patients Admitted to the Department of Infectious Diseases at Santa Maria Hospital, Lisbon (2002 - 2013)].
Grilo V; Pereira A
Acta Med Port; 2016 Oct; 29(10):639-650. PubMed ID: 28103460
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies.
Ding L; Huang H; Wang H; He H
Ann Intensive Care; 2020 Mar; 10(1):34. PubMed ID: 32198645
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children.
Punpanich W; Groome M; Muhe L; Qazi SA; Madhi SA
J Infect Dev Ctries; 2012 Feb; 6(2):109-19. PubMed ID: 22337838
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of positive
Lee HY; Kang HS; Lee HY; Rhee CK; Lee SY; Kim SC; Kim SJ; Park YJ; Kim YK; Kang JY
Korean J Intern Med; 2017 May; 32(3):478-485. PubMed ID: 27951623
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients.
Delclaux C; Zahar JR; Amraoui G; Leleu G; Lebargy F; Brochard L; Schlemmer B; Brun-Buisson C
Clin Infect Dis; 1999 Sep; 29(3):670-2. PubMed ID: 10530464
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.
Tasaka S; Tokuda H
J Infect Chemother; 2012 Dec; 18(6):793-806. PubMed ID: 22864454
[TBL] [Abstract][Full Text] [Related]
18. Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated With Better Outcome.
Wieruszewski PM; Barreto JN; Frazee E; Daniels CE; Tosh PK; Dierkhising RA; Mara KC; Limper AH
Chest; 2018 Sep; 154(3):636-644. PubMed ID: 29705221
[TBL] [Abstract][Full Text] [Related]
19. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of pneumocystis pneumonia from a tertiary care centre in Pakistan.
Sarwar Zubairi AB; Shahzad H; Zafar A
J Pak Med Assoc; 2016 Nov; 66(11):1367-1371. PubMed ID: 27812050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]